| 000 | 01815 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513204229.0 | ||
| 264 | 0 | _c20000518 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a1071-2690 | ||
| 024 | 7 |
_a10.1290/1071-2690(2000)036<0081:RSOUAC>2.0.CO;2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumar, A | |
| 245 | 0 | 0 |
_aRelative sensitivity of undifferentiated and cyclic adenosine 3',5'-monophosphate-induced differentiated neuroblastoma cells to cyclosporin A: potential role of beta-amyloid and ubiquitin in neurotoxicity. _h[electronic resource] |
| 260 |
_bIn vitro cellular & developmental biology. Animal _cFeb 2000 |
||
| 300 |
_a81-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone _xpharmacology |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xpharmacology |
| 650 | 0 | 4 |
_aCyclosporine _xtoxicity |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtoxicity |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeurites _xdrug effects |
| 650 | 0 | 4 | _aNeuroblastoma |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUbiquitins _xmetabolism |
| 700 | 1 | _aHovland, A R | |
| 700 | 1 | _aLa Rosa, F G | |
| 700 | 1 | _aCole, W C | |
| 700 | 1 | _aPrasad, J E | |
| 700 | 1 | _aPrasad, K N | |
| 773 | 0 |
_tIn vitro cellular & developmental biology. Animal _gvol. 36 _gno. 2 _gp. 81-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1290/1071-2690(2000)036<0081:RSOUAC>2.0.CO;2 _zAvailable from publisher's website |
| 999 |
_c10672239 _d10672239 |
||